» Articles » PMID: 34489683

Microglial TREM2 Mitigates Inflammatory Responses and Neuronal Apoptosis in Angiotensin II-Induced Hypertension in Middle-Aged Mice

Overview
Specialty Geriatrics
Date 2021 Sep 7
PMID 34489683
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Growing evidence suggests that hypertension and aging are prominent risk factors for the development of late-onset Alzheimer's disease (LOAD) by inducement of neuroinflammation. Recent study showed that neuroinflammation activated microglia induces reactive astrocytes, termed A1 astrocytes, that highly upregulate numerous classical complement cascade genes that are destructive to neurons in neurodegeneration diseases. Moreover, triggering receptor expressed on myeloid cells 2 (TREM2) is considered as one of the strongest single-allele genetic risk factors and plays important roles in neuroinflammation for LOAD. However, the mechanisms of microglia in the regulation of A1 astrocytic activation are still not clear. We introduced angiotensin II-induced hypertension in middle-aged mice and found that hypertension-upregulated TREM2 expression and A1 astrocytic activation were involved in neuroinflammation in the animal models used in this study. The results revealed that overexpression of microglial TREM2 not only mitigated microglial inflammatory response but also had salutary effects on reverse A1 astrocytic activation and neuronal toxicity.

Citing Articles

Role of caveolin-1 in metabolic programming of fetal brain.

Islam M, Behura S iScience. 2023; 26(10):107710.

PMID: 37720105 PMC: 10500482. DOI: 10.1016/j.isci.2023.107710.


EVOO Polyphenols Exert Anti-Inflammatory Effects on the Microglia Cell through TREM2 Signaling Pathway.

Leri M, Vasarri M, Carnemolla F, Oriente F, Cabaro S, Stio M Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513845 PMC: 10384320. DOI: 10.3390/ph16070933.


Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer's disease: A nationwide population-based cohort study.

Lee H, Kim S, Jo Y, Kim Y, Ye B, Yu Y Front Aging Neurosci. 2023; 15:1137197.

PMID: 36949774 PMC: 10025478. DOI: 10.3389/fnagi.2023.1137197.


Chronic Neuroinflammation and Cognitive Decline in Patients with Cardiac Disease: Evidence, Relevance, and Therapeutic Implications.

Traub J, Frey A, Stork S Life (Basel). 2023; 13(2).

PMID: 36836686 PMC: 9962280. DOI: 10.3390/life13020329.


Thyroid hormone-dependent oligodendroglial cell lineage genomic and non-genomic signaling through integrin receptors.

Emamnejad R, Dass M, Mahlis M, Bozkurt S, Ye S, Pagnin M Front Pharmacol. 2022; 13:934971.

PMID: 36133808 PMC: 9483185. DOI: 10.3389/fphar.2022.934971.


References
1.
Kruyer A, Soplop N, Strickland S, Norris E . Chronic Hypertension Leads to Neurodegeneration in the TgSwDI Mouse Model of Alzheimer's Disease. Hypertension. 2015; 66(1):175-82. PMC: 4465852. DOI: 10.1161/HYPERTENSIONAHA.115.05524. View

2.
Carnevale D, Mascio G, Ajmone-Cat M, DAndrea I, Cifelli G, Madonna M . Role of neuroinflammation in hypertension-induced brain amyloid pathology. Neurobiol Aging. 2010; 33(1):205.e19-29. DOI: 10.1016/j.neurobiolaging.2010.08.013. View

3.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen C . Alzheimer's disease. Lancet. 2021; 397(10284):1577-1590. PMC: 8354300. DOI: 10.1016/S0140-6736(20)32205-4. View

4.
Qiang W, Yau W, Lu J, Collinge J, Tycko R . Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes. Nature. 2017; 541(7636):217-221. PMC: 5233555. DOI: 10.1038/nature20814. View

5.
Tzourio C, Laurent S, Debette S . Is hypertension associated with an accelerated aging of the brain?. Hypertension. 2014; 63(5):894-903. DOI: 10.1161/HYPERTENSIONAHA.113.00147. View